| Product Code: ETC9939851 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) CAR-T Cell Therapy Treatment Market - Industry Life Cycle |
3.4 United Kingdom (UK) CAR-T Cell Therapy Treatment Market - Porter's Five Forces |
3.5 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Structure, 2021 & 2031F |
3.7 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Targeted Antigens, 2021 & 2031F |
3.8 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Brand, 2021 & 2031F |
3.9 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
4 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the UK |
4.2.2 Growing adoption of personalized medicine |
4.2.3 Favorable reimbursement policies for CAR-T cell therapy in the UK |
4.3 Market Restraints |
4.3.1 High cost associated with CAR-T cell therapy |
4.3.2 Limited awareness among patients and healthcare professionals about CAR-T cell therapy |
5 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Trends |
6 United Kingdom (UK) CAR-T Cell Therapy Treatment Market, By Types |
6.1 United Kingdom (UK) CAR-T Cell Therapy Treatment Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Autologous CAR-T Cells, 2021- 2031F |
6.1.4 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Allogeneic CAR-T Cells, 2021- 2031F |
6.2 United Kingdom (UK) CAR-T Cell Therapy Treatment Market, By Structure |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By First Generation CAR-T Cells, 2021- 2031F |
6.2.3 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Second Generation Car-T Cells, 2021- 2031F |
6.2.4 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Third Generation CAR-T Cells, 2021- 2031F |
6.2.5 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Fourth Generation CAR-T Cells, 2021- 2031F |
6.3 United Kingdom (UK) CAR-T Cell Therapy Treatment Market, By Targeted Antigens |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Antigens on Solid Tumors, 2021- 2031F |
6.3.3 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Antigens on Hematologic Malignancies, 2021- 2031F |
6.4 United Kingdom (UK) CAR-T Cell Therapy Treatment Market, By Brand |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Yescarta, 2021- 2031F |
6.4.3 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Kymriah, 2021- 2031F |
6.4.4 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Tecartus, 2021- 2031F |
6.5 United Kingdom (UK) CAR-T Cell Therapy Treatment Market, By Therapeutic Application |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Hematological Malignancies, 2021- 2031F |
6.5.3 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.5.4 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.5.5 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.5.6 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Gastric Cancer, 2021- 2031F |
6.5.7 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Multiple Myeloma, 2021- 2031F |
7 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Export to Major Countries |
7.2 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Imports from Major Countries |
8 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Key Performance Indicators |
8.1 Average waiting time for CAR-T cell therapy treatment |
8.2 Number of CAR-T cell therapy centers in the UK |
8.3 Patient satisfaction levels with CAR-T cell therapy treatment |
9 United Kingdom (UK) CAR-T Cell Therapy Treatment Market - Opportunity Assessment |
9.1 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Structure, 2021 & 2031F |
9.3 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Targeted Antigens, 2021 & 2031F |
9.4 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Brand, 2021 & 2031F |
9.5 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
10 United Kingdom (UK) CAR-T Cell Therapy Treatment Market - Competitive Landscape |
10.1 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) CAR-T Cell Therapy Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here